nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.1	0.258	CbGbCtD
Paliperidone—HTR1B—dura mater—ankylosing spondylitis	0.0638	0.452	CbGeAlD
Paliperidone—HTR1D—dura mater—ankylosing spondylitis	0.0617	0.437	CbGeAlD
Paliperidone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0517	0.133	CbGbCtD
Paliperidone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0501	0.129	CbGbCtD
Paliperidone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0392	0.101	CbGbCtD
Paliperidone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0336	0.0862	CbGbCtD
Paliperidone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0332	0.0851	CbGbCtD
Paliperidone—CYP3A4—Prednisone—ankylosing spondylitis	0.0313	0.0803	CbGbCtD
Paliperidone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0307	0.0789	CbGbCtD
Paliperidone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0195	0.0502	CbGbCtD
Paliperidone—HTR2A—vertebral column—ankylosing spondylitis	0.00922	0.0653	CbGeAlD
Paliperidone—ADRA2C—tendon—ankylosing spondylitis	0.00196	0.0139	CbGeAlD
Paliperidone—HRH1—tendon—ankylosing spondylitis	0.0016	0.0113	CbGeAlD
Paliperidone—ADRA2A—tendon—ankylosing spondylitis	0.00157	0.0111	CbGeAlD
Paliperidone—HTR2A—tendon—ankylosing spondylitis	0.00133	0.00944	CbGeAlD
Paliperidone—Vertigo—Betamethasone—ankylosing spondylitis	0.00064	0.00136	CcSEcCtD
Paliperidone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000639	0.00136	CcSEcCtD
Paliperidone—Syncope—Betamethasone—ankylosing spondylitis	0.000639	0.00136	CcSEcCtD
Paliperidone—Syncope—Dexamethasone—ankylosing spondylitis	0.000639	0.00136	CcSEcCtD
Paliperidone—Infection—Triamcinolone—ankylosing spondylitis	0.000637	0.00136	CcSEcCtD
Paliperidone—Infection—Methylprednisolone—ankylosing spondylitis	0.000635	0.00135	CcSEcCtD
Paliperidone—Shock—Triamcinolone—ankylosing spondylitis	0.000631	0.00134	CcSEcCtD
Paliperidone—Insomnia—Prednisolone—ankylosing spondylitis	0.00063	0.00134	CcSEcCtD
Paliperidone—Alopecia—Prednisone—ankylosing spondylitis	0.00063	0.00134	CcSEcCtD
Paliperidone—Shock—Methylprednisolone—ankylosing spondylitis	0.000629	0.00134	CcSEcCtD
Paliperidone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000628	0.00134	CcSEcCtD
Paliperidone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000627	0.00134	CcSEcCtD
Paliperidone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000626	0.00133	CcSEcCtD
Paliperidone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000626	0.00133	CcSEcCtD
Paliperidone—Epistaxis—Methotrexate—ankylosing spondylitis	0.000626	0.00133	CcSEcCtD
Paliperidone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000626	0.00133	CcSEcCtD
Paliperidone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000625	0.00133	CcSEcCtD
Paliperidone—Mental disorder—Prednisone—ankylosing spondylitis	0.000624	0.00133	CcSEcCtD
Paliperidone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000624	0.00133	CcSEcCtD
Paliperidone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000621	0.00132	CcSEcCtD
Paliperidone—Erythema—Prednisone—ankylosing spondylitis	0.000621	0.00132	CcSEcCtD
Paliperidone—Malnutrition—Prednisone—ankylosing spondylitis	0.000621	0.00132	CcSEcCtD
Paliperidone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000619	0.00132	CcSEcCtD
Paliperidone—Convulsion—Betamethasone—ankylosing spondylitis	0.000617	0.00132	CcSEcCtD
Paliperidone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000617	0.00132	CcSEcCtD
Paliperidone—Hypertension—Betamethasone—ankylosing spondylitis	0.000615	0.00131	CcSEcCtD
Paliperidone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000615	0.00131	CcSEcCtD
Paliperidone—Myalgia—Betamethasone—ankylosing spondylitis	0.000607	0.00129	CcSEcCtD
Paliperidone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000607	0.00129	CcSEcCtD
Paliperidone—Anxiety—Betamethasone—ankylosing spondylitis	0.000605	0.00129	CcSEcCtD
Paliperidone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000605	0.00129	CcSEcCtD
Paliperidone—Discomfort—Betamethasone—ankylosing spondylitis	0.000599	0.00128	CcSEcCtD
Paliperidone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000599	0.00128	CcSEcCtD
Paliperidone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000598	0.00127	CcSEcCtD
Paliperidone—Pain—Prednisolone—ankylosing spondylitis	0.000596	0.00127	CcSEcCtD
Paliperidone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000588	0.00125	CcSEcCtD
Paliperidone—Vision blurred—Prednisone—ankylosing spondylitis	0.000585	0.00125	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000584	0.00124	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000584	0.00124	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000583	0.00124	CcSEcCtD
Paliperidone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000582	0.00124	CcSEcCtD
Paliperidone—Oedema—Betamethasone—ankylosing spondylitis	0.000582	0.00124	CcSEcCtD
Paliperidone—Oedema—Dexamethasone—ankylosing spondylitis	0.000582	0.00124	CcSEcCtD
Paliperidone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000582	0.00124	CcSEcCtD
Paliperidone—Insomnia—Triamcinolone—ankylosing spondylitis	0.00058	0.00124	CcSEcCtD
Paliperidone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000578	0.00123	CcSEcCtD
Paliperidone—Infection—Betamethasone—ankylosing spondylitis	0.000578	0.00123	CcSEcCtD
Paliperidone—Infection—Dexamethasone—ankylosing spondylitis	0.000578	0.00123	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000576	0.00123	CcSEcCtD
Paliperidone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000575	0.00123	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000574	0.00122	CcSEcCtD
Paliperidone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000574	0.00122	CcSEcCtD
Paliperidone—Anaemia—Prednisone—ankylosing spondylitis	0.000574	0.00122	CcSEcCtD
Paliperidone—Shock—Betamethasone—ankylosing spondylitis	0.000572	0.00122	CcSEcCtD
Paliperidone—Shock—Dexamethasone—ankylosing spondylitis	0.000572	0.00122	CcSEcCtD
Paliperidone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000571	0.00122	CcSEcCtD
Paliperidone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00057	0.00122	CcSEcCtD
Paliperidone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00057	0.00122	CcSEcCtD
Paliperidone—Agitation—Prednisone—ankylosing spondylitis	0.00057	0.00122	CcSEcCtD
Paliperidone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000569	0.00121	CcSEcCtD
Paliperidone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000569	0.00121	CcSEcCtD
Paliperidone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000568	0.00121	CcSEcCtD
Paliperidone—Tachycardia—Betamethasone—ankylosing spondylitis	0.000568	0.00121	CcSEcCtD
Paliperidone—Angioedema—Prednisone—ankylosing spondylitis	0.000567	0.00121	CcSEcCtD
Paliperidone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000564	0.0012	CcSEcCtD
Paliperidone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000563	0.0012	CcSEcCtD
Paliperidone—Malaise—Prednisone—ankylosing spondylitis	0.00056	0.00119	CcSEcCtD
Paliperidone—Vertigo—Prednisone—ankylosing spondylitis	0.000557	0.00119	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—ankylosing spondylitis	0.000557	0.00119	CcSEcCtD
Paliperidone—Syncope—Prednisone—ankylosing spondylitis	0.000556	0.00119	CcSEcCtD
Paliperidone—Tinnitus—Methotrexate—ankylosing spondylitis	0.000555	0.00118	CcSEcCtD
Paliperidone—Anorexia—Betamethasone—ankylosing spondylitis	0.000554	0.00118	CcSEcCtD
Paliperidone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000554	0.00118	CcSEcCtD
Paliperidone—Urticaria—Prednisolone—ankylosing spondylitis	0.000554	0.00118	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000553	0.00118	CcSEcCtD
Paliperidone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000553	0.00118	CcSEcCtD
Paliperidone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000551	0.00118	CcSEcCtD
Paliperidone—Pain—Triamcinolone—ankylosing spondylitis	0.000548	0.00117	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000545	0.00116	CcSEcCtD
Paliperidone—Hypotension—Betamethasone—ankylosing spondylitis	0.000543	0.00116	CcSEcCtD
Paliperidone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000543	0.00116	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—ankylosing spondylitis	0.00054	0.00115	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000538	0.00115	CcSEcCtD
Paliperidone—Convulsion—Prednisone—ankylosing spondylitis	0.000538	0.00115	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000537	0.00114	CcSEcCtD
Paliperidone—Hypertension—Prednisone—ankylosing spondylitis	0.000536	0.00114	CcSEcCtD
Paliperidone—Chills—Methotrexate—ankylosing spondylitis	0.000535	0.00114	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00053	0.00113	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00053	0.00113	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—ankylosing spondylitis	0.000528	0.00113	CcSEcCtD
Paliperidone—Myalgia—Prednisone—ankylosing spondylitis	0.000528	0.00113	CcSEcCtD
Paliperidone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000528	0.00113	CcSEcCtD
Paliperidone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000527	0.00112	CcSEcCtD
Paliperidone—Anxiety—Prednisone—ankylosing spondylitis	0.000526	0.00112	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—ankylosing spondylitis	0.000526	0.00112	CcSEcCtD
Paliperidone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000526	0.00112	CcSEcCtD
Paliperidone—Insomnia—Betamethasone—ankylosing spondylitis	0.000526	0.00112	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000525	0.00112	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000523	0.00111	CcSEcCtD
Paliperidone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000522	0.00111	CcSEcCtD
Paliperidone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000522	0.00111	CcSEcCtD
Paliperidone—Discomfort—Prednisone—ankylosing spondylitis	0.000522	0.00111	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000522	0.00111	CcSEcCtD
Paliperidone—Erythema—Methotrexate—ankylosing spondylitis	0.000519	0.00111	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000519	0.00111	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000513	0.00109	CcSEcCtD
Paliperidone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000512	0.00109	CcSEcCtD
Paliperidone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000512	0.00109	CcSEcCtD
Paliperidone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000509	0.00109	CcSEcCtD
Paliperidone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000508	0.00108	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000508	0.00108	CcSEcCtD
Paliperidone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000507	0.00108	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000506	0.00108	CcSEcCtD
Paliperidone—Oedema—Prednisone—ankylosing spondylitis	0.000506	0.00108	CcSEcCtD
Paliperidone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000506	0.00108	CcSEcCtD
Paliperidone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000506	0.00108	CcSEcCtD
Paliperidone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000506	0.00108	CcSEcCtD
Paliperidone—Infection—Prednisone—ankylosing spondylitis	0.000503	0.00107	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000502	0.00107	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000502	0.00107	CcSEcCtD
Paliperidone—Back pain—Methotrexate—ankylosing spondylitis	0.000502	0.00107	CcSEcCtD
Paliperidone—Fatigue—Betamethasone—ankylosing spondylitis	0.000501	0.00107	CcSEcCtD
Paliperidone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000501	0.00107	CcSEcCtD
Paliperidone—Shock—Prednisone—ankylosing spondylitis	0.000498	0.00106	CcSEcCtD
Paliperidone—Pain—Dexamethasone—ankylosing spondylitis	0.000497	0.00106	CcSEcCtD
Paliperidone—Pain—Betamethasone—ankylosing spondylitis	0.000497	0.00106	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000497	0.00106	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—ankylosing spondylitis	0.000494	0.00105	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—ankylosing spondylitis	0.000492	0.00105	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000489	0.00104	CcSEcCtD
Paliperidone—Anorexia—Prednisone—ankylosing spondylitis	0.000483	0.00103	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000481	0.00103	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—ankylosing spondylitis	0.000479	0.00102	CcSEcCtD
Paliperidone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000479	0.00102	CcSEcCtD
Paliperidone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000479	0.00102	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000476	0.00101	CcSEcCtD
Paliperidone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000476	0.00101	CcSEcCtD
Paliperidone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000472	0.00101	CcSEcCtD
Paliperidone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000471	0.001	CcSEcCtD
Paliperidone—Malaise—Methotrexate—ankylosing spondylitis	0.000468	0.000997	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—ankylosing spondylitis	0.000466	0.000993	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000464	0.00099	CcSEcCtD
Paliperidone—Urticaria—Betamethasone—ankylosing spondylitis	0.000462	0.000985	CcSEcCtD
Paliperidone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000462	0.000985	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000461	0.000984	CcSEcCtD
Paliperidone—Dizziness—Prednisolone—ankylosing spondylitis	0.000461	0.000982	CcSEcCtD
Paliperidone—Asthenia—Triamcinolone—ankylosing spondylitis	0.00046	0.00098	CcSEcCtD
Paliperidone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00046	0.00098	CcSEcCtD
Paliperidone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00046	0.00098	CcSEcCtD
Paliperidone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00046	0.00098	CcSEcCtD
Paliperidone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00046	0.00098	CcSEcCtD
Paliperidone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000459	0.000978	CcSEcCtD
Paliperidone—Insomnia—Prednisone—ankylosing spondylitis	0.000458	0.000976	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000455	0.000969	CcSEcCtD
Paliperidone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000453	0.000967	CcSEcCtD
Paliperidone—Cough—Methotrexate—ankylosing spondylitis	0.000453	0.000965	CcSEcCtD
Paliperidone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000452	0.000964	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—ankylosing spondylitis	0.000449	0.000958	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000446	0.00095	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000441	0.000941	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—ankylosing spondylitis	0.000441	0.000941	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—ankylosing spondylitis	0.000441	0.000941	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—ankylosing spondylitis	0.00044	0.000938	CcSEcCtD
Paliperidone—Rash—Prednisolone—ankylosing spondylitis	0.000439	0.000937	CcSEcCtD
Paliperidone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000439	0.000936	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000438	0.000935	CcSEcCtD
Paliperidone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000438	0.000933	CcSEcCtD
Paliperidone—Fatigue—Prednisone—ankylosing spondylitis	0.000437	0.000931	CcSEcCtD
Paliperidone—Headache—Prednisolone—ankylosing spondylitis	0.000437	0.000931	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—ankylosing spondylitis	0.000436	0.00093	CcSEcCtD
Paliperidone—Constipation—Prednisone—ankylosing spondylitis	0.000433	0.000923	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—ankylosing spondylitis	0.000427	0.00091	CcSEcCtD
Paliperidone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000424	0.000903	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000423	0.000902	CcSEcCtD
Paliperidone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000423	0.000901	CcSEcCtD
Paliperidone—Infection—Methotrexate—ankylosing spondylitis	0.00042	0.000896	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000417	0.00089	CcSEcCtD
Paliperidone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000417	0.000889	CcSEcCtD
Paliperidone—Asthenia—Betamethasone—ankylosing spondylitis	0.000417	0.000889	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000415	0.000885	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000414	0.000883	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000414	0.000883	CcSEcCtD
Paliperidone—Nausea—Prednisolone—ankylosing spondylitis	0.000414	0.000882	CcSEcCtD
Paliperidone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000411	0.000877	CcSEcCtD
Paliperidone—Pruritus—Betamethasone—ankylosing spondylitis	0.000411	0.000877	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000411	0.000876	CcSEcCtD
Paliperidone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000407	0.000869	CcSEcCtD
Paliperidone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000407	0.000867	CcSEcCtD
Paliperidone—Rash—Triamcinolone—ankylosing spondylitis	0.000404	0.000861	CcSEcCtD
Paliperidone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000404	0.000861	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—ankylosing spondylitis	0.000403	0.00086	CcSEcCtD
Paliperidone—Rash—Methylprednisolone—ankylosing spondylitis	0.000403	0.000859	CcSEcCtD
Paliperidone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000403	0.000859	CcSEcCtD
Paliperidone—Urticaria—Prednisone—ankylosing spondylitis	0.000402	0.000858	CcSEcCtD
Paliperidone—Headache—Triamcinolone—ankylosing spondylitis	0.000401	0.000856	CcSEcCtD
Paliperidone—Headache—Methylprednisolone—ankylosing spondylitis	0.000401	0.000854	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—ankylosing spondylitis	0.0004	0.000853	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—ankylosing spondylitis	0.0004	0.000853	CcSEcCtD
Paliperidone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000398	0.000848	CcSEcCtD
Paliperidone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000398	0.000848	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—ankylosing spondylitis	0.000395	0.000843	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000386	0.000822	CcSEcCtD
Paliperidone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000385	0.00082	CcSEcCtD
Paliperidone—Dizziness—Betamethasone—ankylosing spondylitis	0.000385	0.00082	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—ankylosing spondylitis	0.000383	0.000816	CcSEcCtD
Paliperidone—Nausea—Triamcinolone—ankylosing spondylitis	0.000381	0.000812	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00038	0.00081	CcSEcCtD
Paliperidone—Nausea—Methylprednisolone—ankylosing spondylitis	0.00038	0.00081	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000377	0.000804	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—ankylosing spondylitis	0.000376	0.000802	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000373	0.000795	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000373	0.000794	CcSEcCtD
Paliperidone—Vomiting—Betamethasone—ankylosing spondylitis	0.00037	0.000788	CcSEcCtD
Paliperidone—Vomiting—Dexamethasone—ankylosing spondylitis	0.00037	0.000788	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000368	0.000784	CcSEcCtD
Paliperidone—Rash—Dexamethasone—ankylosing spondylitis	0.000367	0.000782	CcSEcCtD
Paliperidone—Rash—Betamethasone—ankylosing spondylitis	0.000367	0.000782	CcSEcCtD
Paliperidone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000366	0.000781	CcSEcCtD
Paliperidone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000366	0.000781	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000365	0.000779	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—ankylosing spondylitis	0.000365	0.000778	CcSEcCtD
Paliperidone—Headache—Dexamethasone—ankylosing spondylitis	0.000364	0.000777	CcSEcCtD
Paliperidone—Headache—Betamethasone—ankylosing spondylitis	0.000364	0.000777	CcSEcCtD
Paliperidone—Asthenia—Prednisone—ankylosing spondylitis	0.000363	0.000775	CcSEcCtD
Paliperidone—Pain—Methotrexate—ankylosing spondylitis	0.000362	0.000772	CcSEcCtD
Paliperidone—Pruritus—Prednisone—ankylosing spondylitis	0.000358	0.000764	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000349	0.000743	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000346	0.000739	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000346	0.000738	CcSEcCtD
Paliperidone—Nausea—Dexamethasone—ankylosing spondylitis	0.000345	0.000736	CcSEcCtD
Paliperidone—Nausea—Betamethasone—ankylosing spondylitis	0.000345	0.000736	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—ankylosing spondylitis	0.000336	0.000717	CcSEcCtD
Paliperidone—Dizziness—Prednisone—ankylosing spondylitis	0.000335	0.000714	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000335	0.000713	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000335	0.000713	CcSEcCtD
Paliperidone—Vomiting—Prednisone—ankylosing spondylitis	0.000322	0.000686	CcSEcCtD
Paliperidone—Rash—Prednisone—ankylosing spondylitis	0.000319	0.000681	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—ankylosing spondylitis	0.000319	0.00068	CcSEcCtD
Paliperidone—Headache—Prednisone—ankylosing spondylitis	0.000317	0.000676	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000312	0.000665	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—ankylosing spondylitis	0.000304	0.000647	CcSEcCtD
Paliperidone—Nausea—Prednisone—ankylosing spondylitis	0.000301	0.000641	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—ankylosing spondylitis	0.000299	0.000638	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00029	0.000617	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—ankylosing spondylitis	0.00028	0.000597	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—ankylosing spondylitis	0.000269	0.000574	CcSEcCtD
Paliperidone—Rash—Methotrexate—ankylosing spondylitis	0.000267	0.000569	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000267	0.000568	CcSEcCtD
Paliperidone—Headache—Methotrexate—ankylosing spondylitis	0.000265	0.000565	CcSEcCtD
Paliperidone—Nausea—Methotrexate—ankylosing spondylitis	0.000251	0.000536	CcSEcCtD
